| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
4 companies
Sofinnova Venture Partners Ix, L.P. is a 10% Owner at NextCure, Inc. with holdings across 4 companies. Recent SEC Form 4 filings include 5 buys and 2 sells.
Estimated insider holdings value: $28.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2020 | ITRM Iterum Therapeutics Plc | 10% Owner | Sell | 500,000 | $1.62 | $812,080.00 | -14.9% | |
| Nov 15, 2019 | NXTC Nextcure, Inc. | 10% Owner | Buy | 150,000 | $36.75 | $5,512,500.00 | +5.9% | |
| Nov 12, 2019 | GRTX Galera Therapeutics, Inc. | 10% Owner | Buy | 750,000 | $12.00 | $9,000,000.00 | +32.1% | |
| May 13, 2019 | NXTC Nextcure, Inc. | 10% Owner | Buy | 400,000 | $15.00 | $6,000,000.00 | +18.9% | |
| May 30, 2018 | ITRM Iterum Therapeutics Plc | 10% Owner | Buy | 500,000 | $13.00 | $6,500,000.00 | +40.8% | |
| May 12, 2015 | ATYR Atyr Pharma Inc | 10% Owner | Buy | 320,000 | $14.00 | $4,480,000.00 | +20.7% |